⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ZBIO News
Zenas BioPharma, Inc. Common Stock
Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event
globenewswire.com
ZBIO
Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences
globenewswire.com
ZBIO
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ZBIO
Form 8-K
sec.gov
ZBIO
Zenas BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
ZBIO
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ZBIO
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ZBIO
Zenas BioPharma to Present at the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
globenewswire.com
ZBIO
Zenas BioPharma Announces Data from the Registrational Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD), Simultaneously Presented at the EULAR 2026 Congress and Published in the New England Journal of Medicine
globenewswire.com
ZBIO
Zenas BioPharma Announces Submission of Biologics License Application (BLA) to U.S. FDA for Obexelimab in IgG4-RD
globenewswire.com
ZBIO